T1D-Plus study with Dexcom

T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023. An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring devi...